Intravenous Fentanyl Increases Natural Killer Cell Cytotoxicity and Circulating CD16+ Lymphocytes in Humans
Authors:
- Mark P. YeagerMYMark P. Yeager
- Marcia A. ProcopioMPMarcia A. Procopio
- Joyce A. DeLeoJDJoyce A. DeLeo
- Janice L. ArrudaJAJanice L. Arruda
- Laurie HildebrandtLHLaurie Hildebrandt
- Alexandra L. HowellAHAlexandra L. Howell
- 1 January 2002
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 94 (1) , 94-99
Abstract
Opioids, including fentanyl, are often administered to patients who may be at risk for the consequences of impaired immune function. We performed a clinical study to test the effects of the synthetic opioid fentanyl on human immune function. Participants received an IV fentanyl initial dose of 3 microg/kg followed by a 2-h IV infusion of 1.2 microg x kg(-1) x h(-1). Peripheral blood was drawn before and after fentanyl administration to test for neutrophil phagocytic function, neutrophil antibody-dependent cell cytotoxicity, natural killer cell cytotoxicity, percentage of lymphocyte populations, T-lymphocyte proliferative response, and in vivo antibody response to a pneumococcal vaccine inoculation given at the end of the fentanyl infusion. Fentanyl exposure under the conditions of this study caused a rapid and significant increase in natural killer cell cytotoxicity, which was coincident with an increase in the percentage of CD16(+) and CD8(+) cells in peripheral blood. Fentanyl did not significantly affect any of the other immune measurements. Many previous studies have suggested that opioid drugs can impair immune resistance in patients who may be at risk for infection. This study suggests that the opioid fentanyl, when given to healthy humans without coexisting diseases, does not suppress immune resistance. On the basis of these results, the use of fentanyl should not be restricted because of concerns that it may suppress immune function.Keywords
This publication has 14 references indexed in Scilit:
- The In Vivo Effects of General and Epidural Anesthesia on Human Immune FunctionAnesthesia & Analgesia, 2001
- Inhibition of swine microglial cell phagocytosis of cryptococcus neoformans by femtomolar concentrations of morphineBiochemical Pharmacology, 1997
- Equianalgesic Doses of Subcutaneous but Not Intrathecal Morphine Alter Phenotypic Expression of Cell Surface Markers and Mitogen-induced Proliferation in Rat LymphocytesAnesthesiology, 1996
- Morphine Inhibits Spontaneous and Cytokine-enhanced Natural Killer Cell Cytotoxicity in VolunteersAnesthesiology, 1995
- Catecholamines induce alterations of distribution and activity of human natural killer (NK) cellsJournal of Clinical Immunology, 1993
- Effect of morphine and β-endorphin on human Fc receptor-dependent and natural killer cell functionsClinical Immunology and Immunopathology, 1992
- β-Endorphin's modulation of lymphocyte proliferation is dose, donor, and time dependentBrain, Behavior, and Immunity, 1990
- Differential effects of β-endorphin fragments on human natural killingBrain, Behavior, and Immunity, 1987
- Morphine and methadone impact on human phagocytic physiologyInternational Journal of Immunopharmacology, 1985
- Effect of Morphine on Resistance to InfectionThe Journal of Infectious Diseases, 1983